Pfizer Inc. Suddenly Faces Stiff Breast Cancer Drug Competition From Novartis

Pfizer Inc. had been just the only player in a very specific breast cancer treatment game, but now Novartis has entered the race with a brand new drug that could be a blockbuster and threaten Pfizer’s dominance.